Prevail Therapeutics' Corporate Minority Round

Prevail Therapeutics raised a round of funding on August 10, 2017. Investors include RegenxBio.

Prevail Therapeutics was created by Regenxbio and Orbimed to focus on new biologics and gene therapies for Parkinson's disease.…

Articles about Prevail Therapeutics' Corporate Minority Round: